Contradictorily, by immunohistochemistry method, no expression of uroplakin III was observed in prostate adenocarcinomas across many studies11–14, yielding specificity of 100% in determining the origin as the bladder. This evidence concerns the gene UPK3A and prostate adenocarcinoma.